BioProcess 360 Partners
Overview
BioProcess 360 Partners is a private equity and advisory firm that provides growth capital and hands-on expertise for emerging technologies in the bioprocessing sector.
Portfolio Companies
4
Website
bioprocess360.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ChromaGenix | Apr 2025 | Corporate Funding | Lead |
| Abselion | Dec 2024 | Series A | Co-investor |
| IRUBIS | Aug 2024 | Pre Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioProcess 360 Partners based?
BioProcess 360 Partners is headquartered in Delray Beach, Florida, United States.
When was BioProcess 360 Partners founded?
Founding year information for BioProcess 360 Partners is not publicly available.
How many portfolio companies does BioProcess 360 Partners have?
BioProcess 360 Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in BioProcess 360 Partners's portfolio?
Portfolio companies visible on Caplight include ChromaGenix, Abselion, IRUBIS.
What was BioProcess 360 Partners's most recent investment shown here?
BioProcess 360 Partners's most recent investment in this portfolio sample was in ChromaGenix in 2025.
What sectors does BioProcess 360 Partners focus on?
BioProcess 360 Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does BioProcess 360 Partners focus on?
BioProcess 360 Partners typically invests at the Early stage.